CRBUNasdaqBiological Products, (No Diagnostic Substances)

Caribou Biosciences, Inc. (CRBU) earnings date, market-implied expected move, and options open interest by expiry

0.45

+0.01 · +1.70%

Regular session13:25 ET

Open0.43Volume3.3MMkt cap$47.2M

Day0.43 – 0.4587%52-wk0.41 – 3.541%

CRBU

Caribou Biosciences, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

No implied move.

Next report

Nov 11

after close · in 8 days

est.Q3 FY26

Calendar

Next report

Last report

−1.86%

vs ±44.6% implied · ×0.04

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Linked news

5hPFE · customerPfizer posts Q3 net income of $3,242 million, revenue $16,583 million
28dCTVA · supplierCorteva Announces Dates for Third Quarter 2026 Earnings Release and Webcast

News

Largest filed tie

13F top-10 QoQ

+61.75%

shares held · 10 largest managers

13F · Jun 30 '26126d lag

137 managers

Top fund weight

0.00%

CRBU weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Caribou Biosciences (CRBU) is expected to report on Nov 11 after close (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 13 '26confirmed±44.6%▼−1.86%×0.04

quarterimplied−45%0+45%realized×

Q2 FY26±44.6%▼−1.86%×0.04

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 30 close

0.18OI · 3 expiries · Oct 30 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

370%Nov 2017d2090%

3650%Jan 1573d0.075,2730%0.07

38+3%Apr 16164d0.031,5120%0.03

ExpiryPutsCallsP/C

Nov 2017d370%2090%0.18

Jan 1573d3650%5,2730%0.07

Apr 16164d38+3%1,5120%0.03

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

No implied move.

Linked exposure

Revenue flow

as filedQ2 FY26

−1619.88%as filednet margin · revenue −37.46% QoQ · −43.79% YoY

Revenue$1M−37.46%

Gross profit$1M100.00%−37.46%

Operating income−$25M−1690.39%+3.58%

Pre-tax income−$24M+3.20%

Net income−$24M−1619.88%+3.20%

Cost of revenue$0—

Operating expenses$27M−6.41%

Other income$1M−11.55%

Source: SEC filings · standardized · QE Jun 30 '26 · bars = % of revenue

Revenue flow

Intraday

15m bars

Hatch = extended hours · ▯ up · ▮ downSource: market data · 13:15 ET

Intraday

Event sensitivity

CPROF ×1.30· ±4.9% vs ±3.8% · 12 releases

eventrelease day|move|up · n×base

CPROFcorporate profits±4.9%5 of 12×1.30

PPIproducer prices±4.5%3 of 10×1.20

PCEpersonal income & outlays±4.1%7 of 19×1.08

GDPgross domestic product±4.0%7 of 19×1.06

FOMCrate decision±2.8%12 of 24×0.74

NFPjobs report±2.5%5 of 10×0.66

CPIconsumer prices±2.3%4 of 10×0.61

Bar = avg |move| to ±5% · tick = ±3.8% avg day · ×base = |move| ÷ ±3.8% · min 6 releases

Earnings history

EPS -0.24 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-0.24	—
Q1 FY26	—	-0.26	—
Q3 FY25	—	-0.30	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod